ENOPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.312200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.772200E-01
Normal-vs-Stage2
6.734400E-01
Normal-vs-Stage3
7.161800E-01
Normal-vs-Stage4
3.068800E-01
Stage1-vs-Stage2
8.477200E-01
Stage1-vs-Stage3
3.712200E-01
Stage1-vs-Stage4
5.163400E-01
Stage2-vs-Stage3
3.234400E-01
Stage2-vs-Stage4
3.359200E-01
Stage3-vs-Stage4
2.266600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.330800E-01
Normal-vs-AfricanAmerican
4.442000E-01
Normal-vs-Asian
9.594600E-01
Caucasian-vs-AfricanAmerican
7.627000E-01
Caucasian-vs-Asian
4.270800E-01
AfricanAmerican-vs-Asian
4.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.867200E-01
Normal-vs-Female
5.544000E-01
Male-vs-Female
5.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.558000E-01
Normal-vs-Age(41-60Yrs)
4.063000E-01
Normal-vs-Age(61-80Yrs)
7.328800E-01
Normal-vs-Age(81-100Yrs)
8.141800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.361000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.361600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.967000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.398100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.276000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.683200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.358000E-01
Normal-vs-Daily Drinker
9.160400E-01
Normal-vs-Weekly Drinker
8.576400E-01
Normal-vs-Occasional Drinker
2.464000E-01
Normal-vs-Social Drinker
5.581600E-01
Non Drinker-vs-Daily Drinker
5.076400E-01
Non Drinker-vs-Weekly Drinker
9.920600E-01
Non Drinker-vs-Occasional Drinker
3.343800E-02
Non Drinker-vs-Social Drinker
3.424600E-01
Daily Drinker-vs-Weekly Drinker
5.981200E-01
Daily Drinker-vs-Occasional Drinker
9.402600E-03
Daily Drinker-vs-Social Drinker
1.840210E-01
Weekly Drinker-vs-Occasional Drinker
9.144200E-02
Weekly Drinker-vs-Social Drinker
3.963800E-01
Occasional Drinker-vs-Social Drinker
5.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.254400E-01
Normal-vs-Grade 2
5.244200E-01
Normal-vs-Grade 3
6.669600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.160000E-01
Grade 1-vs-Grade 3
8.031000E-01
Grade 1-vs-Grade 4
2.254400E-01
Grade 2-vs-Grade 3
4.559200E-01
Grade 2-vs-Grade 4
5.244200E-01
Grade 3-vs-Grade 4
6.669600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.675600E-01
Normal-vs-NonDiabetic
5.697000E-01
Diabetic-vs-NonDiabetic
9.285500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.059800E-01
Normal-vs-NoPancreatitis
6.727800E-01
Pancreatitis-vs-NoPancreatitis
8.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.182400E-01
Normal-vs-N1
6.761600E-01
N0-vs-N1
2.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.096000E-01
Normal-vs-TP53-NonMutant
6.257000E-01
TP53-Mutant-vs-TP53-NonMutant
9.798300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
